NA | Valsartan HCTZ [Northwind Pharmaceuticals] | BioPortfolio

13:14 EST 27th January 2019 | BioPortfolio

Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

NDC: 51655-950-52

MFG: 0591-2316-10

Valsartan HCTZ


30 tablets

Rx only

Lot# NW23790001

Exp Date: 02/2015

Each tablet contains: 160mg of Valsartan and 12.5mg of hydrochlorothiazide, USP

Dosage: See package insert

Store at 68 to 77 degrees F.

Store in a tight, light-resistant container (See USP)

Keep out of reach of children.

Mfg by: Arrow Pharm (Malta) Ltd. Birzebbugia, BBG06, Malta

Distr. by: Watson Pharma, Inc Parsippany, NJ 07054 USA Lot# 3019329

Repackaged by Northwind Pharmaceuticals, Indianapolis, IN 46256


Northwind Pharmaceuticals

Active Ingredients


Drugs and Medications [179 Associated Drugs and Medications listed on BioPortfolio]

Amlodipine and valsartan [sandoz inc]

These highlights do not include all the information needed to use Amlodipine and Valsartan Tablets safely and effectively. See full prescribing information for Amlodipine and Valsartan Tablets. AMLODI...

Valsartan and hydrochlorothiazide [directrx]


Valsartan [lake erie medical dba quality care products llc]

These highlights do not include all the information needed to use Valsartan safely and effectively. See full prescribing information for Valsartan. Valsartan (valsartan) TABLET for ORAL use.Initial U....

Valsartan [cardinal health]

These highlights do not include all the information needed to use valsartan safely and effectively. See full prescribing information for valsartan tablets USP. VALSARTAN tablets USP, for oral useIniti...

Valsartan [alembic pharmaceuticals limited]

These highlights do not include all the information needed to use valsartan tablets safely and effectively. See full prescribing information for valsartan tablets. VALSARTAN Tablets, USP for oral useI...

Clinical Trials [237 Associated Clinical Trials listed on BioPortfolio]

VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan Medoxomil

To evaluate the efficacy of valsartan 160 mg/HCTZ 25 mg in patients not adequately responding to monotherapy with olmesartan medoxomil 40 mg or combination therapy with olmesartan medoxomi...

Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension.

The purpose of the study is to evaluate the safety and efficacy of initial treatment therapy with valsartan/HCTZ versus the initial treatment therapy with monotherapies (valsartan or hydro...

Pharmacokinetic Drug Interaction Study Following co-Administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With Hypertension

The purpose of this study is to determine potential pharmacokinetic drug-drug interaction when three drugs (valsartan, amlodipine, and hydrochlorothiazide) are co-administered.

Safety/Efficacy of Valsartan/Hydrochlorothiazide Combination Compared to Hydrochlorothiazide in Obese Hypertensive Adults

The purpose of this study is to compare the blood pressure lowering efficacy of valsartan/hydrochlorothiazide (HCTZ) compared to hydrochlorothiazide for the treatment of obese hypertensive...

BP-EASE -Effectiveness of Losartan 50 mg/Hydrochlorothiazide (HCTZ) 12.5 mg Versus Valsartan 80 mg/HCTZ 12.5 mg Titrated as Needed in Patients With Essential Hypertension Not Controlled on Monotherapy

To evaluate the blood pressure efficacy between losartan and valsartan at equivalent dosage during a 3 months treatment.

PubMed Articles [36 Associated PubMed Articles listed on BioPortfolio]

Usefulness of a titration algorithm for users of sacubitril/valsartan in a tertiary centre heart failure clinic.

A reduction in the rate of death and hospitalisations in patients with heart failure (HF) with reduced ejection fraction receiving sacubitril/valsartan compared to enalapril was demonstrated in the PA...

Sacubitril/Valsartan and Mexiletine: A Proarrhythmic Combination?

The uptake of sacubitril/valsartan since the PARADIGM study confirmed its beneficial effects on outcomes over enalapril in chronic systolic heart failure has inevitably led to potential interactions w...

A Novel Paradigm For Sacubitril/Valsartan: Beta-Endorphin Elevation As A Contributor To Exercise Tolerance Improvement In Rats With Preexisting Heart Failure Induced By Pressure-Overload.

Simultaneous angiotensin receptor (AT) blockade and neprilysin inhibition with sacubitril/valsartan has been recently approved to treat patients with heart failure (HF). Therapeutic benefits of this t...

Analysis of an impurity, N-nitrosodimethylamine, in valsartan drug substances and associated products using GC-MS.

Valsartan products, commonly used to treat high blood pressure and heart failure, have been recalled in many countries due to the presence of an impurity, N-nitrosodimethylamine (NDMA), in the recalle...

Novel Possibilities in Pharmacotherapy of Patients With Chronic Heart Failure.

In this article we have described clinical pharmacology and data of clinical studies of an innovational drug valsartan + sacubitril in patients with chronic heart failure (CHF). The use of supramolecu...

Quick Search


Relevant Topics

Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Drugs and Medication Quicklinks

Searches Linking to this Drug Record